Comparative Study of Prebiotics for Infants Using a Fecal Culture System: Insights into Responders and Non-Responders

Shijir Xijier Mingat1, Tatsuya Ehara1, Hirohiko Nakamura1

  • 1Health Care & Nutritional Science Institute, R&D Division, Morinaga Milk Industry Co., Ltd., 5-1-83, Higashihara, Zama 252-8583, Japan.

Nutrients
|October 16, 2024
PubMed

Insights

A combination of lactulose, raffinose, and galactooligosaccharides (GOS) effectively promotes infant-type human-residential bifidobacteria (HRB) growth in infant gut microbiota. This blend supports a healthy gut microbiome, similar to breastfed infants.

Area of Science:

  • Microbiology
  • Nutritional Science
  • Pediatrics

Background:

  • Infant gut microbiota is crucial for health and dominated by bifidobacteria.
  • Current infant formulas may not fully support the development of a healthy infant gut microbiome.
  • Developing formulas that promote bifidobacteria is essential for infant health.

Purpose of the Study:

  • To identify prebiotic oligosaccharides that promote the growth of all infant-type human-residential bifidobacteria (HRB).
  • To find a prebiotic combination that minimizes non-responders in infant fecal cultures.
  • To inform the development of infant formulas mimicking breastfed microbiota.

Main Methods:

  • Utilized an infant fecal culture system to test various prebiotic oligosaccharides and their combinations.
  • Assessed the growth-promoting effects of lactulose (LAC), raffinose (RAF), galactooligosaccharides (GOS), and fructooligosaccharides.
  • Cultured samples from seven infants (1.5-10.2 months) with individual or combined oligosaccharides.

Main Results:

  • No single oligosaccharide supported all infant-type HRB; GOS promoted most, excluding *Bifidobacterium longum* subsp. *longum*.
  • The combination of LAC/RAF/GOS demonstrated even and effective promotion of all tested infant-type HRB.
  • Acetate production was highest with GOS or LAC/RAF/GOS, indicating superior efficacy and fewer non-responders.

Conclusions:

  • The LAC/RAF/GOS combination is a promising strategy for promoting a bifidobacteria-rich infant gut microbiota.
  • This finding can guide the formulation of infant formulas to better support infant gut health.
  • Aligning formula-fed infant gut microbiota with that of breastfed infants is achievable with targeted prebiotic interventions.
Abstract

Related Concept Videos

Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...